$1.12
0.19.80%
At Close: -
$1.11
-0.01-0.89%
After Hours: 6:26 PM EDT
15 minutes delayed
NeuroSense Therapeutics
NRSNNASDAQ
NeuroSense Therapeutics (NRSN) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestNeuroSense Therapeutics (NASDAQ:NRSN) Stock Quotes, Forecast and News Summary
NeuroSense Therapeutics Stock (NASDAQ: NRSN) stock price, news, charts, stock research, profile.
| Open | $1.02 |
| Close | $1.12 |
| Volume / Avg. | 509.96K / 126.41K |
| Day Range | 0.96 - 1.14 |
| 52 Wk Range | 0.40 - 2.33 |
| Market Cap | $20.02M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 56 |
| Short Interest | 0.05% |
| Days to Cover | 1 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About
Sector
Healthcare
Industry
N/A
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and dev...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy NeuroSense Therapeutics (NRSN) stock?
You can purchase shares of NeuroSense Therapeutics (NASDAQ:NRSN) through any online brokerage.
Who are NeuroSense Therapeutics (NRSN) competitors?
There are no as such competitors for NeuroSense Therapeutics.
What is the target price for NeuroSense Therapeutics (NRSN) stock?
There is no analysis for NeuroSense Therapeutics.
What is the forecast for NeuroSense Therapeutics (NRSN) stock?
NeuroSense Therapeutics has a consensus price target of $7.25.
Current stock price for NeuroSense Therapeutics (NRSN)?
The stock price for NeuroSense Therapeutics (NASDAQ: NRSN) is $1.11 last updated June 28, 2024 at 6:26 PM EDT.
Does NeuroSense Therapeutics (NRSN) pay a dividend?
There are no upcoming dividends for NeuroSense Therapeutics.
When is NeuroSense Therapeutics (NASDAQ:NRSN) reporting earnings?
NeuroSense Therapeutics’s Q2 earnings are confirmed for Wednesday, August 14, 2024.
Is NeuroSense Therapeutics (NRSN) going to split?
There is no upcoming split for NeuroSense Therapeutics.
What sector and industry does NeuroSense Therapeutics (NRSN) operate in?
NeuroSense Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.